Bridgeway Capital Management, LLC Gain Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.24 - $3.99 $12,400 - $39,900	10,000 Added 33.33%	40,000 $51,000
Q1 2024 May 15, 2024	SELL	$3.21 - $5.04 $51,681 - $81,144	-16,100 Reduced 34.92%	30,000 $113,000
Q2 2023 Aug 14, 2023	SELL	$4.36 - $5.5 $60,604 - $76,450	-13,900 Reduced 23.17%	46,100 $206,000
Q4 2022 Feb 14, 2023	BUY	$2.89 - $3.35 $57,800 - $67,000	20,000 Added 50.0%	60,000 $187,000
Q1 2022 May 16, 2022	SELL	$3.15 - $5.59 $31,500 - $55,900	-10,000 Reduced 20.0%	40,000 $163,000
Q2 2021 Aug 16, 2021	BUY	$8.96 - $15.8 $448,000 - $790,000	50,000 New	50,000 $501,000

2.39M

10K

Ticker GANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,883,400
Market Cap $18.5M
Description
Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.